| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |